Activation-induced cytidine deaminase (AID) is required for both somatic hypermutation and class-switch recombination in activated B cells. AID is also known to target nonimmunoglobulin genes and introduce mutations or chromosomal translocations, eventually causing tumors. To identify as-yet-unknown AID targets, we screened early AID-induced DNA breaks by using two independent genome-wide approaches. Along with known AID targets, this screen identified a set of unique genes (SNHG3, MALAT1, BCL7A, and CUX1) and confirmed that these loci accumulated mutations as frequently as Ig locus after AID activation. Moreover, these genes share three important characteristics with the Ig gene: translocations in tumors, repetitive sequences, and the epigenetic modification of chromatin by H3K4 trimethylation in the vicinity of cleavage sites.
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deep sequencing | end labeling by biotin oligonucleotide | microarray A ctivation-induced cytidine deaminase (AID) is expressed in germinal center (GC) B cells upon antigen stimulation and is essential for two types of genetic alteration in the Ig gene: class switch recombination (CSR) and somatic hypermutation (SHM), which provide the genetic basis for antibody memory (1, 2) . CSR produces antibodies with different effector functions by recombination at Ig heavy chain (H) switch (S) regions, so that the μ-chain constant (Cμ) region is replaced by a downstream C H region. SHM introduces nontemplated point mutations in the rearranged variable (V) region genes, resulting in incremented antigen receptor affinity after clonal selection (3, 4) .
Functional studies on AID mutants have shown that distinct AID domains are required for SHM and CSR, although AID has a single catalytic center (cytidine deaminase motif) in the middle of the molecule. Deletions and alterations in the N-terminal region affect both the CSR and SHM activities (5) . However, AID C-terminal mutants almost completely lose CSR activity but retain or even increase SHM activity (6, 7) . Although C-terminally truncated AID mutants cleave both V and S regions and induce enhanced c-myc-IgH translocations, they cannot mediate CSR, suggesting that the C-terminal domain is not required for DNA cleavage but is required to correctly pair cleaved ends (8) .
The DNA cleavage of targets in CSR and SHM (the S region and V region, respectively) requires their transcription (9) (10) (11) (12) . Indeed, AID-induced mutations (SHM) are generally detected in a region within 2 kb downstream of the transcription start site (TSS) (13, 14) . Transcription appears to play two roles in the targeting of cleavage sites. First, transcription is associated with the epigenetic marking of the target locus, particularly by H3K4 trimethylation (H3K4me3). The histone chaperone complex FACT is required to regulate H3K4me3 in the target S region, and FACT knockdown abolishes H3K4me3 and DNA cleavage in this region (15) . Second, transcription is probably required to induce non-B structures in highly repetitive sequences such as S regions (16) (17) (18) , due to excessive negative supercoiling induced immediately downstream of transcription. V regions have also been shown to form stem-loop structures under these conditions (19, 20) . Non-B structure involvement has recently been reported in transcription-associated mutations in repetitive sequences such as the dinucleotide repeat hot spots or triplet repeat expansion/contractions causing Huntington's disease (17, 21, 22) .
AID-dependent DNA cleavage is, in general, specific to the Ig locus. However, a number of reports have shown that AID can induce DNA cleavage in non-Ig loci. AID non-Ig targets were first demonstrated by studies on AID transgenic mice that produce numerous T lymphomas, in which vast numbers of mutations accumulate in the genes encoding the T-cell receptor, CD4, CD5, c-myc, and PIM1 (23, 24) . This finding was followed by the observations that AID deficiency abolishes c-myc-Ig translocation and reduces the incidence of plasmacytoma (25, 26) . AID expression is specific to activated B cells under normal conditions. However, AID expression has also been found in non-B cells, especially in cells stimulated by infection with pathogens such as human T-cell leukemia virus type 1 (HTLV1), hepatitis C virus (HCV), Epstein-Barr (EB) virus, and Helicobacter pylori (27) (28) (29) (30) . Based on these observations, AID is postulated to induce tumorigenesis, especially in B lymphomas and leukemias-and AID is expressed in many GC-derived human B-cell lymphomas (31) (32) (33) . The prognosis of acute lymphocytic leukemia (ALL) and chronic myeloid leukemia (CML) is linked with AID expression (34, 35) . It is therefore important to determine which non-Ig genes can be targeted by AID, and what features, if any, they share with Ig genes.
Several approaches have been used to explore AID non-Ig target genes in B cells. Candidate approaches involving the direct sequencing of proto-oncogenes, genes involved in translocations, or genes transcribed in normal GC B cells have shown that AID mutates several non-Ig genes, including BCL6, MYC, PIM1, and PAX5 (24, 32, 36, 37) . More recently, several efforts have been made to identify AID targets in a whole genome. These approaches have used chromatin immunoprecipitation (ChIP) of CSR-related proteins in combination with genome-wide tiling microarrays (ChIP-chip) or deep sequencing (ChIP-seq) on the assumption that proteins involved in CSR bind to AID targets. RPA, Nbs1, AID itself, and Spt5 have been used as marking proteins in this type of study (38) (39) (40) . However, these approaches did not necessarily show that all of the protein-bound targets are cleaved or mutated by AID. There are indications that some genes identified by such approaches are not tran-scribed (39) . Therefore, it is important to reexamine non-Ig AID target genes by using a different strategy.
Here, we report four AID targets, identified by a combination of unique techniques. After directly labeling the DNA breakage ends from AID-induced cleavage with a biotinylated linker, we isolated the labeled fragments with streptavidin beads and analyzed them by a combination of promoter arrays and genomewide sequencing. The candidates identified were then confirmed by quantitative PCR (qPCR) and the actual demonstration of mutations. With these methods, we identified at least four previously unknown AID targets-SNHG3, MALAT1, BCL7A, and CUX1. We found that these targets share important characteristics with Ig genes, namely, repetitive sequences that can form non-B structures upon efficient transcription, and the accumulation of H3K4me3 histone modifications on the chromatin.
Results
AID-Induced DNA Cleavage Detected by Labeling DNA Break Ends with a Biotinylated Linker. To detect genome-wide AID-induced DNA breaks, we used a modified in situ DNA end-labeling technique as described (8, 41) in BL2 cells, a Burkitt's lymphoma cell line that serves as an in vitro model for studying the SHM mechanism (31, 42, 43) . We used the BL2 clone BL2-ΔC-AIDER, which expresses JP8Bdel, an AID mutant lacking the Cterminal 16 residues, fused with the hormone-binding domain of the estrogen receptor (ER) (JP8Bdel-ER). Tamoxifen (4-OHT) treatment induces DNA breakage in the Sμ and Sα regions but not in the Sγ region of JP8Bdel-ER-expressing CH12 cells, which switch almost exclusively from IgM to IgA (8) .
BL2-ΔC-AIDER cells were treated with 4-OHT only for 3 h to minimize cell death and DNA break ends were labeled with a biotinylated linker, and the break-enriched biotinylated DNA was used as a PCR template (Fig. 1A ). In agreement with previous reports (8, 42) , we detected DNA breakage in the 5′ Sμ region of the IgH locus only in 4-OHT-treated cells. No breakage was detected in the B2M gene, which is expressed in BL2 cells but was shown not to accumulate mutations in activated B cells (Fig. 1B) .
AID Targets Identified by Promoter Array and Whole Genome
Sequencing. Because SHM is normally detected close to the TSS (13, 14) , biotin linker-enriched DNA fragments were analyzed by a promoter array to identify unknown AID targets. Table S1 lists the genes whose signals increased after 3 h of 4-OHT treatment, compared with untreated samples with false discovery rate (FDR) values <0.3. We also looked for genes with increased signals after 4-OHT treatment that are known to be targets of chromosomal translocation or genes that had multiple breakage peaks, and we identified >50 genes, among which we found that BCL7A and CUX1 are enriched in the original breakage-enriched library by qPCR (see below). We confirmed by RT-PCR and expression array that SNHG3, MALAT1, NIN, C9orf72, CFLAR, SNX25, BCL7A, and CUX1 were transcribed in BL2 cells (Table S1 ). Fig. S1 shows the peak signals in a 10-kb segment surrounding the breakage area of SNHG3, MALAT1, BCL7A, and CUX1. We could not map the breakage in the Ig locus because of the absence of array probes in this region.
Because the promoter array does not detect DNA fragments outside of regions containing probes, we further analyzed the breakage-enriched DNA by direct sequencing of the biotin linker-enriched library. DNA breakage sites in both control and 4-OHT-treated libraries were identified by aligning sequenced tags to the genome, and significantly enriched regions were identified by comparing the local breakage density (SI Materials and Methods). Regions were identified in the genes listed in Table S2 . Interestingly, SNHG3 and MALAT1, which were identified by the promoter array, appear at the top of the list in the genome-wide sequencing as well. Fig. 1C shows the chromosomal distribution of AID target candidates identified by promoter array or whole-genome sequencing. Breakage seemed to be distributed through the genome without any apparent bias. Surprisingly, of the 29 candidates identified by whole-genome sequencing with strict statistical parameters, only two matched candidates obtained from the promoter array. This discrepancy might be explained in part because most of the breakage-rich regions detected by whole genome sequencing are located in regions that do not contain promoter array probes.
Results may also be limited because of possible bias by PCR amplification of the primary library for microarray and wholegenome sequencing, which could affect the relative genome coverage. To avoid this bias, we relied on the original library and confirmed all candidates by qPCR.
qPCR Analyses of Linker Libraries. To confirm the AID-induced breakage candidates detected by the promoter array and wholegenome sequencing, we used qPCR assays with gene-specific primers to amplify the vicinity of the identified breakage regions in biotin linker-enriched DNA from cells treated with 4-OHT for 3 h (Fig. 2) . We examined whether candidate genes were enriched in the 4-OHT-treated DNA library compared with the nontreated library. Among the 29 candidates identified by wholegenome sequencing, only SNHG3 and MALAT1 were strongly enriched (P < 0.0001 and P < 0.001, respectively). Besides these, BCL7A, CUX1, and CFLAR, which were picked up only by the promoter array, also showed significant enrichment (P < 0.01) in the 4-OHT-treated library.
We also confirmed that the Sμ and V regions in BL2 cells were cleaved, because they were enriched in the 4-OHT-treated library. Although MYC, which is translocated in an AID-dependent manner in human Burkitt's lymphoma (44), was not identified by either promoter array or whole-genome sequencing, qPCR of the 4-OHT-treated samples clearly revealed MYC gene enrichment (Fig. 2) . The difference in cleavage detection between the direct candidate qPCR and genome-wide arrays and sequencing suggests that the amplification step required for microarray and whole-genome sequencing methods may introduce bias, either for or against many genes. In the case of sequencing, this bias can lead to low mapping coverage of certain regions, hampering efforts to identify significant enrichment. Therefore, we cannot exclude genes that were not identified by the present methods from being AID targets.
AID Targets Accumulate Somatic Mutations near Cleavage Sites. To test whether the newly identified target genes are mutated upon AID activation, we treated BL2-ΔC-AIDER cells with 4-OHT for 24 h and sequenced regions of ≈600 bp around each area with abundant breakage (Fig. S2 and Table S3 ). Mutations increased in all of the qPCR-confirmed AID target genes after 4-OHT treatment (Fig. 2, Inset) , with mutation frequencies ranging from 6. ), and are far higher than that of the control B2M gene (4.3 × 10 −5 ). We also detected mutations in the CFLAR gene; however, the mutation frequency (9.2 × 10 ) was not as high as other AID target genes, although mutations increased significantly in 4-OHTtreated sample (P = 0.004) (Table S3) .
To compare the distribution profiles of mutated bases and AID-induced DNA breaks in the biotin linker-enriched DNA, we mapped the linker positions by performing ligation-mediated (LM)-PCR with the linker primer and gene-specific primers. These PCR fragments were subsequently cloned and sequenced. Break ends identified by the linker were plotted, together with mutation positions (Fig. 3 and Fig. S2) . The results clearly showed that the DNA cleavage marks (biotin linker) were closely associated with mutations, indicating that the DNA cleavage sites identified are functionally relevant to SHM by AID. We used RT-PCR and expression arrays to confirm that the regions Fig. 2 . qPCR measurement of DNA breaks. Break signals are presented relative to Sμ. SD values were derived from at least three independent experiments, and P values were calculated by a two-tailed t test. *P < 0.01, **P < 0.001, ***P < 0.0001. Numbers below the x axis indicate the ratio between samples treated and not treated with 4-OHT. (Inset) Mutation analysis of genes with significantly increased break signals after AID activation. Cells were treated with or without 4-OHT for 24 h. Only unique mutations were counted. Detailed mutation profiles can be found in Fig. S2 and Table S3 . where DNA cleavage and mutations were identified are transcribed (Tables S1 and S2 ).
Repetitive Sequences Surround the Breakage Regions of Unique
Targets. We next examined common features among the AID targets. Although SHM has been reported to prefer the RGYW-WRCY motif (46), we could not find any enrichment of this motif among the break sites in the newly identified targets. It was recently reported that mutations are introduced in regions with sequences prone to forming non-B DNA structure, including tandem repeats, palindromes, and inverted repeats (17, 18) . The S region, MYC, and V region genes contain sequences prone to forming non-B structure (19, 20, 47, 48) . We used REPFIND, a program that identifies clustered, nonrandom short repeats in a given nucleotide sequence, to search the vicinity of identified breakage regions for sequences prone to forming non-B structure. For each repeat cluster, a P value is calculated indicating the probability of finding such a repeat cluster randomly (a P value of 1 × 10 −5 means that such a concentration of that particular repeat occurs an average of once in 100,000 bp by chance) (49) . Curiously, we found that various types of repeat sequences cluster in the vicinity of cleaved sites in the newly identified AID target genes. In the MALAT1 locus, the region within 2 kb surrounding the breakage peaks was rich in clustered short repeat motifs such as GAAG, GCC, GAA, CCG, AAG, GAAGA, and TTAA (Fig. 4) . Repeat clusters were also found near the cleavage sites of the SNHG3, BCL7A, and CUX1 loci. (Fig. S3) . In all cases, the probability of the appearance of these repeats was far below random (P < 1 × 10 −8 ).
H3K4me3 at Cleavage Sites. It was recently shown that S region transcription alone is not sufficient for CSR; specific histone posttranslational modification marks, especially H3K4me3, are required. H3K4me3 depletion strongly inhibits CSR and DNA cleavage in the Sμ and Sα regions (15) . We thus asked whether the V region and the newly identified AID targets also carry H3K4me3 marks around the cleavage regions. ChIP analysis showed that both the V region and MALAT1 locus were abundantly marked by H3K4me3 (Fig. 5) . Furthermore, the H3K4me3 distribution profiles corresponded well to the somatic mutation distribution in the rearranged V region and to the breakage signal distribution observed by both the promoter array and whole genome sequencing in MALAT1 (Fig. 5 A and B) . Mutations identified in MALAT1 overlapped with DNA cleavage signals and H3K4me3 marks (Figs. 3 and 5B). We examined the H3K4me3 pattern of other AID targets by using publicly available EN-CODE ChIP-seq data for the B-lymphoblastoid cell line GM12878 (51) . As expected, all of them, except for BCL7A, were highly abundant in H3K4me3 marks overlapping nicely with cleavage sites (Fig. S4 ). H3K4me3 might be absent at the BCL7A locus in GM12878 cells because it is an inducible gene expressed in BL2 cells, but not in the GM12878 cell line (52) . We thus conclude that the newly identified AID targets share both cis and trans marks for AID targeting-non-B structure and H3K4me3, respectively (15, 16) .
Discussion
Identified AID Targets Accumulate High-Frequency Mutations. We explored AID targets by combining three different strategies: promoter array, whole genome sequencing, and candidate qPCR in a library containing biotinylated linker-labeled cleaved ends. With these strong criteria, we were able to identify four unique AID targets: SNHG3, MALAT1, BCL7A, and CUX1. All of these candidates were further confirmed to accumulate mutations. These candidates are thus strong AID cleavage targets; however, these genes represent only very efficient AID targets. The use of the biotinylated linker, which efficiently identifies double-strand breakage with close, staggered nicks on opposite strands, may not detect scattered nicks efficiently, and this may limit identification to targets that are efficiently and specifically cleaved within 3 h of AID activation. Some well-described SHM target genes, including MYC, BCL6, PAX5, RHOH, and PIM1, were not detected by either the promoter array or whole genome sequencing. We used qPCR to test whether these genes were enriched in the biotin-labeled DNA library, but only MYC was enriched in the 4-OHT-treated sample (Fig. 2) . These genes have been found to be mutated in memory and GC B cells as well as lymphoma cells (24, 32, 36, 37) , cells that are expected to be chronically exposed to AID. In addition, the mutation accumulation in tumor cells depends on selection. In contrast, in our study, we exposed BL2 cells to a short treatment (3 h) of 4-OHT, to increase the chance of detecting only efficiently targeted loci. In fact, none of the genes above mentioned mutated more than 1/20th of the 3′ J H locus even in 6-mo-old Peyer's patch B cells (36) .
The unique AID targets accumulate mutations at comparable frequencies with the Ig and MYC genes. We found that the mutation and cleavage sites are located in similar areas. The results indicate that the cleavage and mutation sites are linked, but not necessarily identical. This observation is consistent with the prediction that SHM is incorporated during the repair phase by error-prone polymerases (53) . We confirmed that all of the newly identified AID targets were highly transcribed in BL2 cells. Although the breakage signal detected at the BCL7A locus was ≈800 bp upstream of the TSS, we detected both sense and antisense transcripts in this region.
Unique AID Targets also Translocate. Furthermore, it is important to stress that all of these unique candidates have been shown to be the targets of chromosomal translocation in neoplastic cells as shown for the Ig locus and MYC gene. MALAT1 is overexpressed in several cancers and was reported to be involved in regulating alternative splicing (54) . The MALAT1 locus has been found to harbor chromosomal translocation breakpoints associated with cancer (45, 55) and, interestingly, two reported translocation breakpoints are close to or within the breakage region identified in the present study (Fig. 3) . SNHG3, a host gene for small nucleolar RNAs (56) , is also reported to be involved in translocation, and although the exact position of the translocation breakpoint has not been reported, we can speculate that it is located in the second intron of SNHG3 because the detected fusion transcript joins the second exon of SNHG3 with the exon of the 3′ partner gene (57) . BCL7A and CUX1 have also been reported to bear chromosomal translocations; however, these translocation breakpoints occur far from the breakage regions identified in this study (58, 59) .
Abundant Repetitive Sequences in AID Targets. To identify common features of AID targets, we compared the MYC, SNHG3, MALAT1, CUX1, and BCL7A genes with the Ig gene locus (the V H gene and the Sμ region). Sequence analysis identified abundant repetitive sequences surrounding the cleaved regions of AID targets. A typical example is MALAT1 (Fig. 4): The GAAG, GCC, GAA, CCG, AAG, GAAGA, and TTAA repeats are highly abundant within 2 kb surrounding the break peaks, which also overlap with actual mutation sites. In the SNHG3 locus, less frequent but longer repeats-GGATTACAG, TTT-TTGTATTTT, ATTACAGGC, GCCTC, and TTTTTGTA-are clustered in the proximity of cleavage sites (Fig. S3A ). BCL7A and CUX1 have GC-rich repeats, such as CGCG, CCGCG, CCCG, and CGGCG (Fig. S2 B and C) . The MYC gene, the V region, and the S region are already known to have repetitive sequences or inverted repeats that can form non-B structure when the target is actively transcribed and under an excessive negative superhelical condition (19, 20, 47, 48) .
H3K4me3 Marks in AID Targets. Chromatin modifications are also involved in AID targeting. We showed that H3K4 methylation, specifically trimethylation, is critical for DNA cleavage in the S region (15), although Odegard et al. (60) showed that the H3K4 dimethylation (H3K4me2) pattern is similar among VJλ1, Cλ1, and Eλ3-1 and concluded that H3K4me2 is not correlated with SHM. Association of H3K4me3 with the MYC locus was also reported (38) . Therefore, we tested whether H3K4me3 modification is also associated with the V region and the unique loci. SHM in V regions typically targets the whole coding V-region segment and extends to its 5′ and 3′ flanking regions. Mutation frequencies rise sharply ≈100 bp downstream of the TSS (at the middle of the leader intron), peak in V(D)J, and then gradually decrease after the immediate 3′ flanking region, becoming undetectable over a distance of ≈1 kb from the rearranged J (61). It is striking that the H3K4me3 profile follows the exact same tendency as SHM distribution in the V region (Fig. 5A) . H3K4me3 is scarce in the leader exon and intron but present in the highly mutated portion of the V(D)J exon. We also observed that H3K4me3 distribution at the MALAT1 locus corresponded well with the breakage signal distribution detected by both the promoter array and whole genome sequencing (Fig. 5B and Fig.  S3A ). The H3K4me3 pattern of other AID targets also overlaps with cleavage sites (Fig. S3 B-D) . Strikingly, we observed a strong H3K4me3 peak in the 5′ region of the CUX1 gene (Fig.  S4D) , which does not contain microarray probes. We confirmed that this region also accumulates mutations after 4-OHT treatment (Table S3 ). It would be interesting to check whether H3K4me3 depletion can decrease AID-induced breaks and mutations in the newly identified AID targets.
We thus conclude that all of these genes, SNHG3, MALAT1, BCL7A, and CUX1, share unique characteristics that are required for AID targeting: non-B structure as the cis element and the H3K4me3 histone modification as the trans mark.
Materials and Methods
Labeling of DNA Break Ends by a Biotinylated Linker. The biotin-labeled DNA break assay was performed as described (8) with slight modifications. After nuclear permeabilization, BL2 cells were washed with cold PBS and resuspended in 1× T4 DNA polymerase buffer. Blunting was performed by using T4 DNA Polymerase (Takara). After washing with cold PBS, 4 μL of T4 DNA Ligase (Takara) and 13.4 μL of an annealed biotinylated P1 linker were added, and the cells were incubated overnight at 16°C. Genomic DNA was purified by phenol:chloroform extraction.
PCR, Real-Time PCR, and LM-PCR. Biotinylated genomic DNA (10 μg) was sonicated (Covaris) and incubated with 10 μL of M-270 Dynabeads (Invitrogen) for 15 min at room temperature. After washing, the beads were resuspended in 15 μL of TE buffer and used as a PCR template. PCR was initiated by denaturing for 5 min at 95°C followed by 25 cycles (95°C for 30 s, 60°C for 30 s, and 72°C for 30 s) and a final extension at 72°C for 5 min. SYBR Green Master Mix (Applied Biosystems) was used for real-time PCR.
For LM-PCR, we used a template of 1 μL of beads in a two-round PCR by using linker primer (P1-LM) and gene-specific primers. First-round PCR was initiated by nick translation (72°C for 20 min), followed by denaturing (95°C for 5 min), 25 cycles (95°C for 15 s, 65°C for 15 s, and 70°C for 1 min), and a final extension (70°C for 5 min). Second-round PCR included denaturing (95°C for 5 min), 20 cycles (95°C for 15 s, 65°C for 15 s, and 70°C for 1 min), and a final extension (70°C for 7 min). The PCR fragments were purified, cloned with the pGEM-T Easy Vector System (Promega), and sequenced with the ABI PRISM 3130xl Genetic Analyzer (Applied Biosystems). Primers sequences are provided in Table S4-S7. DNA Preparation for Microarray and SOLiD Sequencing. After sonication of biotin-labeled genomic DNA, sheared ends were blunted by adding T4 DNA polymerase for 30 min at room temperature. DNA was purified by using the PureLink PCR purification Kit (Invitrogen), P2-annealed linker was ligated overnight at 16°C, DNA was incubated with Dynabeads as described above, and the beads were used for global amplification by following the SOLiD protocol (Applied Biosystems). A summary of general features of the sequenced libraries can be found in Fig. S5 and Table S8 .
